HULL CARL
Known title: Chief Executive OfficerCIK: 0001205465
HULL CARL's purchase track record
HULL CARL has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/11/2024 | MRVI | $987K | -25.6% | -63.3% | -2.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| MRVI | ▲ Buy | Open Market | 175,000 | $987K | 11/11/2024 | View on chart |
| MRVI | ▼ Sell | Tax Withholding | 17,560 | $135K | 3/15/2024 | View on chart |
| MRVI | ▼ Sell | Tax Withholding | 10,729 | $59K | 2/15/2024 | View on chart |
| MRVI | ▲ Buy | Grant | 75,842 | — | 1/16/2024 | View on chart |
| MRVI | ▲ Buy | Grant | 147,638 | — | 3/15/2023 | View on chart |
| MRVI | ▼ Sell | Tax Withholding | 9,719 | $148K | 2/15/2023 | View on chart |
| MRVI | ▲ Buy | Grant | 81,600 | — | 1/25/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Maravai LifeSciences Releases Q2 2026 Earnings Call Transcript
Maravai LifeSciences has published the full transcript of its second-quarter 2026 earnings call. This document provides detailed management commentary on recent operational performance and financial results. The release serves as a primary source for investors seeking to understand the company's current strategic direction and outlook.
Maravai LifeSciences Releases Q2 2026 Earnings Call Transcript. Maravai LifeSciences has published the full transcript of its second-quarter 2026 earnings call. This document provides detailed management commentary on recent operational performance and financial results. The release serves as a primary source for investors seeking to understand the company's current strategic direction and outlook.